Litcius/Paper detail

First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial

Si‐Yang Maggie Liu, Hai‐Yan Tu, Xue‐Wu Wei, Hong‐Hong Yan, Xiaorong Dong, Jiuwei Cui, Zhen Zhou, Chong‐Rui Xu, Ming-Ying Zheng, Yang-Si Li, Zhen Wang, Xiaoyan Bai, Anna Li, Yue‐Li Sun, Jie Huang, Jiaxin Lin, Erjing Ke, Bing-Fei Xu, Chang Lu, Yingying Du, Yuan Chen, Rui Ma, Buhai Wang, Shundong Cang, Bin-Chao Wang, Hua‐Jun Chen, Jin‐Ji Yang, Yangqiu Li, Qing Zhou, Yi‐Long Wu, Qing Zhou, Yi‐Long Wu

2023Nature Medicine61 citationsDOI

Topics & Concepts

MutantLung cancerMedicineCancer researchOncologyBioinformaticsBiologyInternal medicineComputational biologyGeneticsGeneLung Cancer Treatments and MutationsHER2/EGFR in Cancer ResearchPeptidase Inhibition and Analysis